CIK 0001704287
- Emerging growth company
Bluejay Diagnostics, Inc.
Sign in to watch- Ticker
- BJDX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473552922
- Phone
- +1 978-631-0152
- Business address
- 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, 01720
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $1.16 ($2,898)
- 4 Open-market buy Director bought 10,000 shares at $1.18 ($11,830)
- 4 Open-market buy Director bought 40,000 shares at $1.18 ($47,120)
- 4 Open-market buy Director bought 60,000 shares at $1.09 ($65,400)
- 4 Open-market buy Chief Financial Officer bought 16,000 shares at an average $0.97 ($15,530)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 3 · 59 filings